LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences:
- Canaccord Genuity 2026 Musculoskeletal Conference – New Orleans, March 2, 2026, 9:30 am CT
- TD Cowen 46th Annual Health Care Conference – Boston, March 3, 2026, 11:10 am ET
Interested parties can access the live and archived webcast of the presentations in the “Events & Presentations” section of the Orthofix Investor Relations Website at ir.orthofix.com.
Internet Posting of Information
Orthofix regularly shares important updates in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.
About Orthofix
Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH™ Navigation System. Learn more about our surgical and therapeutic solutions at Orthofix.com and follow us on LinkedIn.
Contacts
Company Contact:
Investors and Media
Julie Dewey, IRC
Chief Investor Relations & Communications Officer
[email protected]
209.613.6945
